INTRODUCTION
In skeletal muscle excitation-contraction (EC) coupling, intracellular calcium (Ca 2+ ) stored in the sarcoplasmic reticulum (SR) is released by the ryanodine receptor (RyR), a massive homotetrameric Ca 2+ -release channel, and this released Ca 2+ then triggers muscle cell contraction. Three mammalian RyR isoforms exist: RyR1 and RyR2 govern EC coupling in skeletal and cardiac muscle, respectively, whereas RyR3 is expressed in many tissues at low levels (Giannini et al., 1995; Jeyakumar et al., 1998; Nakai et al., 1990; Otsu et al., 1990; Takeshima et al., 1989; Zorzato et al., 1990) . Although the three RyR isoforms share about 65% sequence identity (Hakamata et al., 1992) , three major regions of sequence divergence have been identified: divergent region 2 (DR2) (RyR1 residues 1,342-1,403); DR3 (RyR1 residues 1,872-1,923); and DR1 (RyR1 residues 4,254-4,631) ( Figure 1A ) (Sorrentino and Volpe, 1993) . These DRs underlie functional differences between the different RyR isoforms. DR2 has been implicated in mechanical coupling between RyR1 and the voltage-dependent L-type Ca 2+ channel (Ca v 1.1) a 1 subunit (Perez et al., 2003) , which is essential for skeletal-type EC coupling. DR3, which includes a stretch of 30 negatively charged amino acid residues in RyR1 , has been implicated in Ca 2+ -and Mg 2+ -dependent regulation of the RyR (Bhat et al., 1997) , and may also interact with the II-III loop of the Ca v 1.1 a 1 subunit (Proenza et al., 2002) . Finally, DR1 is predicted to contain a large unstructured cytoplasmic loop flanked by two transmembrane (TM) segments Takeshima et al., 1989; Zorzato et al., 1990) . Mutations in DR1 alter Ca 2+ and caffeine sensitivity of RyR1 (Bhat et al., 1997; Hayek et al., 1999 Hayek et al., , 2000 .
To understand the role of these regions in RyR1 function, it is essential to determine their locations within the 3D structure of the channel. In cryoelectron microscopic (cryo-EM) reconstructions, the RyR is composed of a large cytoplasmic domain and a much smaller TM assembly that contains the Ca 2+ channel (Radermacher et al., 1994; Samsó et al., 2005 Samsó et al., , 2009 Serysheva et al., 1999; Sharma et al., 2000) . The corners of the cytoplasmic assembly are known as ''clamp'' regions, which themselves are connected by ''handles'' (Figure 1B) . Previous studies have mapped these DRs to the cardiac muscle RyR (RyR2) cryo-EM map by inserting GFP into each DR of RyR2 and then comparing the resulting map with wild-type (WT) (Liu et al., 2002 (Liu et al., , 2004 Zhang et al., 2003) . The inserted GFPs appear as excess densities when subtracting cryo-EM maps of WT RyR2 from GFP-RyR2, and the locations of these densities have been assumed to correspond to the DR locations. However, uncertainty exists about the positions of these regions because the cryo-EM mapping method localizes the fused GFP, rather than its insertion site. Significant distances may separate the fused GFP from its insertion site (Raina et al., 2012) , due to the physical dimensions of GFP and the lengthy poly-Gly linkers often used to tether it to the RyR. These issues may have led to discrepancies between sequence regions localized to the cryo-EM map using protein fusions, compared with docking of atomic structures of RyR fragments derived from the same locations (Liu et al., 2001; Tung et al., 2010) . In this study, we used fluorescence resonance energy transfer (FRET)-based trilateration to localize these DR sequence elements to the RyR1 cryo-EM map. This method relies on FRETbased distance measurements taken between small fluorescent probes targeted to specific sites on RyR1 using donor-labeled variants of the FK506-binding protein (FKBP) and small FRET acceptors targeted to decahistidine (His 10 ) ''tags.'' Our results map these DRs to different RyR1 surface locations, where they may play diverse roles in channel function, including mediating EC coupling and interacting with RyR-associated proteins.
RESULTS

Experimental Strategy
We employed a cell-based FRET approach to localize the RyR1 DRs to the RyR1 cryo-EM map ( Figure 1A ). We targeted FRET donors to RyR1 using fluorescent variants of FKBP (12.6 kDa isoform), which bind with nanomolar affinity between the RyR1 clamp and handle regions, far from its 4-fold axis of symmetry ( Figure 1B ) (Cornea et al., 2010; Samsó et al., 2006) . A set of five fluorescent donor-labeled FKBPs (D-FKBPs) was produced via covalent attachment of Alexa Fluor 488 (AF488) to each of five engineered cysteine substitutions at well-distributed FKBP12.6 surface positions ( Figure 1C ) (Girgenrath et al., 2013) . The locations of these AF488 donors relative to their attachment sites in FKBP12.6 were determined from simulated annealing calculations ( Figure 1C , green spheres). In human embryonic kidney 293T (HEK293T) cells, we targeted these D-FKBPs to separate RyR1 constructs that each contained a His 10 tag inserted into one of the three RyR1 DRs ( Figure 1D ). We then measured FRET from each of these five donor-labeled positions to two different FRET acceptors (Cy3 nitrilotriacetic acid [NTA] and Cy5NTA) that bind to these His 10 tags but have different distance sensitivities (defined by the Fö rster distance, R 0 , at which 50% FRET occurs), resulting from differing spectral overlaps with AF488 ( Figure S1 available online). Distances calculated from these dual FRET measurements were then used to identify loci corresponding to the position of Cy3NTA or Cy5NTA relative to FKBP docked to its known location on the RyR1 cryo-EM map (Cornea et al., 2010; Samsó et al., 2006) . FRET measurements from GFP fusions within RyR1 to Cy3NTA targeted to these His 10 tags were used to further constrain the trilateration results obtained using D-FKBPs. The His 10 -tagged positions within the RyR1 cryo-EM map were then determined from surfaces on the RyR1 cryo-EM map closest to the acceptor locus that satisfied all constraints.
R 0 for the AF488-Cy5NTA Donor-Acceptor Pair Previously (Girgenrath et al., 2013) , we used the AF488/Cy3NTA donor-acceptor pair to trilaterate multiple positions within the RyR1 ''ABC'' domain, the N-terminal atomic structure that has been docked to the RyR1 cryo-EM map (Tung et al., 2010) . From spectral overlap ( Figure S1 ), we had calculated a theoretical R 0 of 66 Å for this donor-acceptor pair. However, not all factors affecting R 0 are measurable, so we corrected this R 0 for our experimental system using FRET measurements between fixed reference points on the docked FKBP12 and ABC domain. From these fixed points, we derived an optimized R 0 of 59 Å for AF488/Cy3NTA that resulted in trilaterations of ABC domain positions that colocalized well with the actual His 10 insertion sites in the ABC domain. In the current study, we performed a similar optimization of the AF488/Cy5NTA R 0 value by trilaterating a His 10 tag placed at position 500 (Figure 2 ), within the ''C'' domain spanning amino acid residues 393-559 (Tung et al., 2010) . D-FKBP bound specifically to HEK293T cells expressing the His 500 -RyR1 construct (Figure 2A ), which released Ca 2+ in response to caffeine with a similar EC 50 as WT RyR1 ( Figure 2B ). FRET measured from each of the five D-FKBP donor positions to Cy3NTA targeted to His 500 ranged from 0.18 (for D14-FKBP) to 0.63 (for D32-FKBP) ( Figure 2C ), whereas FRET to Cy5NTA was lower from each donor position (as expected based on lower spectral overlap; Figure S1 ). However, the pattern of FRET efficiencies using these two acceptors was remarkably similar ( Figure 2C ). Using an R 0 of 53 Å for AF488/Cy5NTA to derive donor-acceptor distances from each of the five D-FKBP positions to Cy5NTA bound to His 500 -RyR1, we trilaterated a locus only 20 Å from residue 500 ( Figures 2D and 2E ). Using the Cy3NTA-derived FRET data and an R 0 of 59 Å we previously determined for the AF488/Cy3NTA FRET pair, we trilaterated a second locus 25 Å from the His 10 tag insertion site and 7.5 Å from the locus derived from the Cy5NTA-based FRET data ( Figures  2D and 2E) . These experiments and analysis validated an R 0 of 53 Å for the AF488/Cy5NTA pair, which we then used in parallel trilaterations of the RyR1 DRs (see below). These experiments also provided an estimate of the accuracy of our trilateration method, which is affected by the linker between the acceptor fluorophore and its NTA moiety, and on the His 10 insert. Taken together, these factors may offset the acceptor probe by up to 25 Å from the His 10 tag insertion site, as we observed for the His 500 -RyR1 construct. These constraints were used to map the His tag insertions in the RyR1 DRs (see below).
Analysis of FKBP Binding to Constructs Containing His 10
Tags in the RyR1 DRs FKBP12.6 with AF488 conjugated to amino acid residue 14 (D14-FKBP) bound specifically to HEK293T cells expressing WT RyR1 because D-FKBP fluorescence colocalized with RyR1 detected by immunofluorescence ( Figure 3A ). D14-FKBP also bound to RyR1 containing His 10 tags at position 1358(DR2), 1915(DR3), or 4429(DR1) ( Figure 3A ), at levels statistically unchanged compared to WT RyR1 ( Figure 3B ). In contrast, D-FKBP binding to RyR1 containing a His 10 tag at position 1863(DR3) was essentially undetectable ( Figures 3A and 3B ).
Functional Analysis of His 10 -Tagged RyR1 Proteins All His 10 -tagged RyR1 constructs released Ca 2+ in response to caffeine, an RyR agonist ( Figure 4A ). EC 50 values for caffeine activation of these constructs were statistically unchanged compared to WT RyR1 ( Figures 4B and 4C ), thus indicating that the His 10 insertions did not significantly affect RyR1 caffeine sensitivity. The His 10 -tagged construct at position 1863 also released Ca 2+ in response to caffeine as reported previously (Fessenden, 2009) . Figure S2B ). From these curves, binding saturation at 3 mM Cy3/5NTA (used for subsequent FRET-based distance measurements) was used to correct the measured FRET values for trilaterations, as needed. We next measured FRET from each of the five D-FKBP variants to 3 mM Cy3/5NTA FRET acceptors targeted to each His 10 tag. For Cy3NTA targeted to His 10 at RyR1 position 1358 (in DR2), FRET efficiencies (E) ranged from 0.27 for D44-FKBP as donor to 0.43 for D32-FKBP as donor, thus suggesting that these FKBPattached probes were furthest and closest, respectively, to DR2 ( Figure 5A ). In contrast, FRET efficiencies to Cy3NTA targeted to DR3 were very different compared to DR2, ranging from 0.17 for D85-FKBP to 0.58 for D44-FKBP ( Figure 5B ). Finally, E for Cy3NTA targeted to a His 10 tag inserted at RyR1 position 4429 (in DR1) showed relatively little variation, ranging from 0.16 for D32-FKBP to 0.27 for D49-FKBP ( Figure 5C ). Thus, the profiles of FRET efficiencies between FKBP and each of these His 10 insertion sites were completely distinct from each other, which suggest that these sites are in different parts of the RyR1 cryo-EM map. within the cryo-EM map (gray). Loci determined using either the Cy3NTA (red) or Cy5NTA data set (blue) are depicted relative to FKBP (yellow, with numbered red dots indicating attachment sites of AF488 donors) and the insertion site of the His 10 tag (green sphere) within the RyR1 ''C'' domain (purple ribbon structure) docked to the RyR1 cryo-EM map. See also Figure S1 .
We performed a parallel series of FRET measurements using Cy5NTA ( Figure 5 , blue bars). In all cases, FRET efficiencies measured with Cy5NTA were lower compared to equivalent measurements with Cy3NTA ( Figure 5 , red bars), a result consistent with the shorter R 0 for the AF488-Cy5NTA pair. However, the profile of FRET efficiencies measured using these two FRET acceptors was the same to each His 10 -tagged position. This finding supports the conclusion that the observed FRET efficiencies are related to the distances between probes and, thus, are unlikely to be biased by anisotropic acceptor dynamics.
FRET between GFP and Cy3NTA Bound to RyR1 His 10 Tags To further constrain trilaterations using D-FKBPs as donors, we measured FRET from GFP fused at RyR1 position 1 (GFP(1)) or 620 (GFP(620)) to Cy3NTA bound to each of the DR His 10 tags ( Figure 6A ). Because we have previously localized these GFP fusions to the RyR1 cryo-EM map (Raina et al., 2012) , we used these FRET measurements as additional constraints to localize acceptors bound to the DRs. All GFP/His 10 -tagged RyR1 constructs were functional, without significant changes in EC 50 values for caffeine activation, compared with WT RyR1 (Figure S3) . No significant energy transfer was detected from GFP at position 1 to any of the His 10 positions in the DRs ( Figure 6B ), thus suggesting that the GFP donor fused to the RyR1 N terminus is beyond detection range by FRET to the His 10 tags inserted in the DRs. In contrast, we did measure significant energy transfer from GFP(620) to Cy3NTA targeted to DR2 (at position 1358) and both sites within DR3 (positions 1863 and 1915), which had mean FRET efficiencies of 0.22, 0.10, and 0.13, respectively (Figure 6B) . No significant energy transfer was detected from GFP(620) to Cy3NTA targeted to DR1 (position 4429).
Trilateration of DR2
Using these measured FRET values, the position of each His 10 tag within the cryo-EM map was determined via trilateration. For His 1358 (DR2) (Figure 7 ), no locus could be identified that satisfied FRET measurements from all five D-FKBP donors. However, several possible loci were identified from data sets derived from combinations of four FKBP donors ( Figure 7A ). Our hypothesis was that one of these loci represented the location of Cy3NTA bound to His 1358 in DR2. To identify the most likely candidate, we assessed the distance of each of these loci from the surface of the RyR1 cryo-EM map. From the trilateration of His 500 -RyR1 ( Figures 2D and 2E) , we estimated the distance from the His 10 tag insertion site to the FRET-derived locus representing Cy3NTA bound to this position to be no greater than 25 Å . We then reasoned that candidate loci farther than 25 Å from the RyR1 surface could not represent viable locations of the triangulated Cy3NTA and could thus be excluded; in this case, loci lacking the distances derived from the D14-or D44-FKBP-based FRET data, denoted ÀD14a and ÀD44a, respectively ( Figures 7A and 7B ). We refined these trilaterations using FRET measurements from GFP(1) and GFP(620) to DR2 ( Figures 7B and 7C ). Because no FRET was detected from GFP(1) to Cy3NTA bound to His 1358 ( Figure 6B ), we ruled out loci within 90 Å of the fused GFP ($150% of the GFP/Cy3NTA R 0 of 63 Å ; Girgenrath et al., 2013) . This constraint allowed us to eliminate the ÀD14b and ÀD44b loci predicted to be 33 and 53 Å from GFP(1) ( Figure 7B ). This left the ÀD32 locus as the sole candidate for the DR2 trilateration. We used FRET measured from GFP(620) as a positive constraint to verify that this locus was acceptable. The ÀD32 region was within 54 Å of GFP(620) ( Figure 7C ), a distance that should result in detectable FRET between these two positions using these probes, which we did observe (E = 0.22, Figure 6B) . Thus, the ÀD32 locus represents the likely position of Cy3NTA bound to His 1358 in DR2. The cyan-colored zone in Figure 7C represents the portion of the RyR1 cryo-EM map within 15 Å of this locus and, thus, the likely location of the DR2 His 1358 tag. An independent trilateration using FRET data obtained with Cy5NTA as acceptor yielded a similar result ( Figure 7D ).
Trilateration of DR3
We used a similar process to localize position 1915 (DR3) within the RyR1 cryo-EM map (Figure 8 ). In this case, trilateration yielded a single locus that satisfied all five distances measured from FKBP ( Figure 8A ). This candidate locus was $110 Å from GFP(1) ( Figure 8B ), a distance too long to result in detectable FRET, which we did not observe ( Figure 6B ). The candidate locus was 62 Å from GFP(620), a distance compatible with our measured FRET (E = 0.13) ( Figure 6B ). The surface of the RyR1 Figure S2 and Table S1 .
cryo-EM map within 15 Å of this locus was located within subdomain 9, which represents the likely position of His 1915 within DR3 ( Figure 8C ). Distances calculated from FRET measurements obtained using the Cy5NTA acceptor yielded a similar trilateration result ( Figure 8C ).
Trilateration of DR1
For DR1 position 4429 (Figure 9 ), no region in space matched distances from all five donor positions. However, several possible loci were identified from data sets derived from combinations of four FKBP donor positions (Figure 9 ). These loci were refined using the scheme outlined for DR2, which also took into consideration the distance of each locus from the RyR1 TM assembly because the DR1 His 10 tag is located in a cytoplasmic loop between two confirmed TM helices ( Figure S4 ). From these constraints, the locus that excluded the distance from D49-FKBP (ÀD49 in Figure 9 ) represented the most likely location of Cy3NTA bound to the DR1 His 10 ( Figure 9A ). This locus was proximal to the TM assembly and also outside our detection range for FRET from GFP(1) and GFP(620) (Figure 9B ), which we did not observe ( Figure 6B ). From this locus, we identified a patch in subdomain 3 on the RyR1 cryo-EM map that represented the potential location of the His 10 insertion at position 4429 ( Figure 9C ). An independent trilateration of this site using Cy5NTA as acceptor yielded a similar result ( Figure 9C ).
DISCUSSION
FRET Method
Using distances derived from in-cell FRET measurements, we have localized each of the three RyR1 DRs, which are thought to confer isoform-specific functional properties to RyRs. In important previous studies, 3D locations of these sites had been assigned to the RyR2 cryo-EM map from densities corresponding to GFP moieties inserted in each DR (Liu et al., 2004; Zhang et al., 2003) . The FRET-based method we used to localize the DRs within the RyR1 cryo-EM map has several distinct advantages over these methods based on GFP inserts. FKBP12.6, used to target the FRET donor to the RyR, is a physiological RyR-associated protein whose binding location and orientation are well defined and conserved between RyR1 and RyR2 (Cornea et al., 2010) , whereas Cy3NTA and Cy5NTA, the FRET acceptors, bind to small His 10 tags inserted in the RyR1 sequence. Thus, minimal alterations of the native RyR structure are required for these FRET measurements. At the core of our protocol is the geometrical method termed ''trilateration'' to Structure FRET-Based Trilateration of RyR1 Divergent Regions determine the relative location of a site by measuring distances from several well-distributed donor coordinates on FKBP, which we have defined using molecular modeling and simulated annealing (Svensson et al., 2014) . These optimizations of donor positions on FKBP, combined with the well-established binding location and orientation of FKBP on RyR1 (Cornea et al., 2009 (Cornea et al., , 2010 Samsó et al., 2006) , provided the best available accuracy and precision for these trilaterations.
To localize the RyR1 DRs, we used two different FRET acceptors (Cy3NTA and Cy5NTA) with differing distance sensitivity ranges when paired with the AF488 donor. We obtained overlapping trilateration loci with these two donor-acceptor pairs ( Figures 7D, 8C , and 9C). Consistency between measurements using different probes indicated that the FRET-derived distances are accurate. This implies that FRET is insignificantly affected by probe orientation, probably because donors and acceptors undergo isotropic dynamics that are fast relative to the donor fluorescence lifetime (several nanoseconds) (Svensson et al., 2014) . This approach will be expanded in future studies to localize other His-tagged positions in the proximity of RyR-bound D-FKBP donor.
Trilateration of His 10 Tags Inserted in the DRs
Our trilateration results indicate that each DR is located in a different part of the RyR1 cryo-EM map ( Figure 10A ). For example, we localized position 1358 within DR2 to domain 5 of the clamp region ( Figure 7D ). This location is approximately 58 Å from several previous cryo-EM-based localizations of this region within subdomain 6 ( Figure 10B ) (Liu et al., 2004; Murayama and Kurebayashi, 2011; Sharma et al., 2000) . These prior localizations are over 100 Å from the donor probe location in each of our D-FKBP variants, distances that should result in undetectable FRET using our system. Thus, the difference between our FRET-based determination of this position and prior cryo-EM-based results is quite striking. One possible reason for this difference could be underlying local conformational dynamics at the DR2 His 10 tag insertion site. This site is glycine rich and thus could be highly flexible. The effective location of Cy3NTA acceptor bound to this site is near subdomain 5, but flexibility within the loop containing the His 10 tag insertion may result in a ''flopped over'' conformation extending from the subdomain 6 location identified in previous cryo-EM studies. Such flexibility could impart special properties to this region, such as an ability to couple with and transfer conformational signals originating from the Ca v 1.1 channel complex during EC coupling, as has been suggested by functional studies (Perez et al., 2003; Tarroni et al., 1997) . Indeed, our DR2 localization in subdomain 5 faces the t-tubule membrane, where it could form molecular contacts with Ca v 1.1, which has been docked to the RyR1 cryo-EM map in this location ( Figure 10B ) (Wolf et al., 2003) . The conformational dynamics of the DR2 site may best be probed in future studies using fluorescence lifetime-based FRET measurements, which could be used to quantify distance distributions between labeled sites in this region (Li et al., 2012; Muretta et al., 2013) .
Our FRET-based trilateration of His 1915 in DR3 localized this region to subdomain 9 of RyR1 ( Figures 10A and 10C ). This finding is entirely consistent with prior localization of this region using GFP fused at equivalent residue 1908 of RyR2 and subsequent difference density mapping to low-resolution cryo-EM structures (Liu et al., 2002 (Liu et al., , 2004 Zhang et al., 2003) ( Figure 10C ). DR3 has been implicated both in weak interactions with the II-III loop of Ca v 1.1 (Proenza et al., 2002) and in mediating the inhibition of RyR1 by magnesium (Bhat et al., 1997; Hayek et al., 1999 Hayek et al., , 2000 . Because RyR1 activation during EC coupling is thought to occur via relieving magnesium inhibition (Lamb and Stephenson, 1991) , the underlying conformational changes could be occurring within domain 9, a notion supported by observation of conformational changes in the clamp domain using cryo-EM (Orlova et al., 1996; Serysheva et al., 1999) Thus, a structural hypothesis consistent with our localizations of these DRs is that DR2 in RyR1 subdomain 5 transmits conformational changes that occur during EC coupling to DR3 in subdomain 9 to relieve magnesium inhibition of RyR1. Subsequent downstream conformational changes then occur, resulting ultimately in channel opening. D-FKBP did not bind to His 1863 (DR3)RyR1. This region (residues 1,835-1,870 in RyR1) has been implicated as a potential FKBP12.6-binding site in RyR2 (Zhang et al., 2003) . Thus, one possible interpretation of our findings is that the His 10 insertion at position 1863 lies at the FKBP:RyR1 interface where it blocks fluorescent FK506-binding protein 12.6 kDa (F-FKBP) binding. If this is the case, then a polyacidic region containing over 30 negatively charged residues that is unique to RyR1 (residues 1,873-1,920) may lie between the bound FKBP and our localization of position 1915 on the RyR1 cryo-EM maps. We have indicated Values represent mean ± SEM. Asterisks indicate significant differences in FRET relative to non-His-tagged constructs, determined using one-way ANOVA followed by Dunnett's posttest (p < 0.01). See also Figure S3 . a possible placement of the polyacidic region in Figure 10C (orange patch).
Our FRET-based trilaterations suggest that the His 10 tag at position 4429 in DR1 is located in subdomain 3 of the handle region within the RyR1 cryo-EM map. This result is consistent with previous cryo-EM localizations of this region using either GFP fusion at equivalent residue 4,413 in RyR2 (Liu et al., 2002) or polyclonal antibodies raised to amino acids 4,425-4,621 of RyR1 (Benacquista et al., 2000) ( Figure 10D ). Taken together, the results from these studies suggest that DR1 comprises cytosolic domain 3, although DR1 may extend into the TM assembly. From the RyR1 cryo-EM map, domain 3 appears to form a direct structural link with the TM assembly of the RyR1 pore (Radermacher et al., 1994) , suggesting that these domains couple TM and cytoplasmic assemblies during channel activation. This is also suggested by cryo-EM localizations indicating that both physiological and pathophysiological RyR1 modulators, such as calmodulin and Imperatoxin A, bind to RyR1 within the cleft between domains 3 and 7 adjacent to DR1 (Samsó et al., 1999; Wagenknecht et al., 1997; Wagenknecht and Samsó , 2002) . Indeed, our localization of DR1 overlaps with previous cryo-EM localizations of apo-CaM in RyR1 and RyR2 Huang et al., 2012) . A second line of evidence provides additional support for the role of DR1 in modulating RyR1 activity, including potential roles in Ca 2+ activation and inactivation of RyR1 as well as caffeine activation (Bhat et al., 1997; Du et al., 2000; Hayek et al., 1999 Hayek et al., , 2000 .
Perspective
In conclusion, we have used FRET-based trilateration to localize the RyR DRs to the RyR1 3D map. This technique can theoretically be used to localize any RyR sequence site that is exposed to the cytosol and, thus, has the potential to resolve the location of many other physiologically relevant primary structure elements in the cryo-EM map of RyR1. In the future, we intend to use this method to resolve dynamic structural changes within the DRs in response to physiological regulation, in order to gain additional insights into their specific roles in RyR1 channel function.
EXPERIMENTAL PROCEDURES
RyR1 cDNA Cloning and Expression cDNAs encoding full-length His 10 -tagged rabbit RyR1 within the pCi-Neo mammalian expression vector (Promega) were created as follows. The cDNA encoding His 500 -RyR1 was initially generated within a RyR1 subclone spanning amino acid positions 1-1645 of rabbit RyR1 created using the NheI restriction site in the pCi mammalian expression vector and the naturally occurring AgeI site within the RyR1 cDNA (at position 4936). DR2 (amino acid position 1358) or DR3 (positions 1863 and 1915) His 10 tag insertions were initially generated within a RyR1 subclone spanning amino acid positions 1645-2776 of rabbit RyR1, created using the naturally occurring unique RyR1 restriction sites, AgeI (cDNA position 4936) and BsiWI (cDNA position 8328). The cDNA encoding a His 10 tag inserted into DR1 (amino acid position 4429) was initially generated within a RyR1 subclone encoding the C-terminal portion of the protein (amino acids 4,386-5,037) created using a naturally occurring SphI site (cDNA position 13147) and an XbaI site within the cloning vector that lies beyond the RyR1 stop codon. Oligonucleotide primers used for mutagenesis each contained the His 10 tag coding sequence 5 0 -CAC-CAT-CAC-CAT-CAC-CAT-CAC-CAT-CAC-CAT-3 0 , followed by either NcoI (for the His 500 insertion), EcoRV (for DR3 or DR1 His 10 tag insertions) or NdeI (for the DR2 His 10 tag insertion) restriction sites to track successful clones. His 10 tag encoding sites were inserted using primer extension-driven mutagenesis using the Pfusion high-fidelity DNA polymerase (New England Biolabs), and the proper sequence and reading frame were confirmed using bidirectional DNA sequencing. HEK293T cells were grown and transiently transfected with cDNAs encoding these His 10 -tagged RyR1 constructs using polyethylenimine as described (Fessenden, 2009 ). Cells were used in functional or FRET-based assays 2 days after transfection.
Preparation of FRET Donors and Acceptors
Fluorescent derivatives of FKBP12.6 were prepared as previously described (Cornea et al., 2009 (Cornea et al., , 2010 Girgenrath et al., 2013) . Cy3NTA and Cy5NTA were synthesized and purified as described (Fessenden, 2009 FRET Imaging HEK293T cells expressing each His 10 -tagged RyR construct were permeabilized using 0.1% saponin in FRET buffer (125 mM NaCl, 5 mM KCl, 25 mM HEPES, and 6 mM glucose [pH 7.6]). Then, 10 nM F-FKBP and 3 mM Cy3NTA or Cy5NTA were added to the cells and incubated for 60-120 min at 37 C before imaging. FRET was then measured using epifluorescence microscopy. Transfected HEK293T cells expressing each RyR1 construct were illuminated with a 300 W xenon lamp housed within a Lambda DG-4 light source (Sutter Instruments), and donor fluorescence was observed using a YFP cube set (480/30 nm band-pass excitation filter, a 505 nm dichroic mirror, and a 535/40 nm band-pass emission filter; Chroma Technology). Cell fluorescence was measured with a Stanford Photonics XR-Mega 10 CCD camera (Stanford Photonics) as a series of 60 16-bit 672 3 516 pixel images across a z stack 60 mm in thickness. Donor fluorescence was then reacquired after photobleaching the Cy3NTA acceptor for 4 min at maximum light output using a ReAsH cube set (570/ 20 nm excitation, 585 nm dichroic, and 620/60 nm emission; Chroma Technology). Cy5NTA acceptor was photobleached using a 665/30 nm excitation filter and a 700 nm dichroic mirror (Chroma Technology). FRET was calculated using
where E represents the FRET efficiency, and F prebleach and F postbleach indicate donor fluorescence intensities before and after acceptor photobleaching, respectively. Fluorescence from background-corrected images was quantified using ImageJ version 1.45 m (NIH).
Distance Calculations
FRET efficiencies were converted to intramolecular distances using R = R 0 ðð1=EÞ-1Þ 1=6 ; (Equation 2) where R represents the donor/acceptor distance, R 0 represents the Fö rster distance for the donor/acceptor pair (Girgenrath et al., 2013) , and E represents the measured FRET efficiency. R 0 values were 59 and 53 Å for the AF488/ Cy3NTA and AF488/Cy5NTA pairs, respectively (see Results). Distances used for trilaterations are given in Table S1 .
Determination of AF488 Donor Positions Conjugated to FKBP12.6 F-FKBP donor positions were determined computationally using a modification of a previously reported simulated annealing protocol (Svensson et al., , and 85 of the FKBP12 atomic structure docked to RyR1. We then used a simulated annealing protocol (Brü nger et al., 1990) starting with a cycle of six torsion-angle dynamics steps at 300,000 K, followed by cooling at a rate of 500 K per cycle and a 0.75 fs integration time. The fluorescent probe, the cysteine sulfur site of attachment, and the side chains of two to six neighboring residues of FKBP were free to move while everything else in the model was fixed. The movement of the AF488 probe was constrained by the atomic structure of FKBP12 as well as local electron density from the RyR1 cryo-EM map. These simulations produced 10,800 possible conformations of AF488 bound to each location. The average probe location was used for trilaterations.
Trilateration
The optimized AF488 donor locations determined from our simulated annealing protocol for each of the five FKBP attachment sites (14, 32, 44, 49, and 85) , and distances calculated from our measured FRET values (Table S1) , were used to determine a locus in space corresponding to the position of each FRET acceptor bound to each of the inserted His 10 tags. The atomic structure of FKBP12.6 with its attached FRET donors was docked to the RyR1 cryo-EM map in the closed conformation (EMD ID #1607) (Samsó et al., 2009 ). Trilateration was performed as described (Girgenrath et al., 2013) . Briefly, spheres were created around each of the FKBP12.6 donor positions with radii equivalent to FRET-derived distances (Table S1) , and thickness was arbitrarily assigned as 20% of the measured FRET-based distance. Then pairwise intersections of each of these spheres were identified as rings corresponding to spatial volumes derived from distances from two of the FKBP12.6 donor positions. Then intersections of each of these rings were identified, corresponding to loci derived from four of the five FRET-based distances. Finally, each of these loci was paired with the remaining sphere derived from the fifth FRETbased distance, resulting in the final locus corresponding to distances from all five donor positions. These loci were visualized as volumes using UCSF Chimera build 39231, and distance measurements to these volumes were taken from dummy atoms placed on their surfaces using Chimera.
FKBP/RyR1 Colocalization
Relative D-FKBP binding to each His 10 -tagged RyR1 construct was determined by comparing D-FKBP fluorescence intensity to the expression level of each construct using anti-RyR immunocytochemistry. HEK293T cells expressing His 10 -tagged constructs were loaded with 10 nM D14-AF488 FKBP for 60-120 min as described above (see FRET Imaging). After washing three times with PBS, cells were fixed in 0.5% formalin for 30 min. After washing and a 30 min blocking in 2.5% normal goat serum and 0.1% saponin, cells were treated 30 min with 34C anti-RyR monoclonal antibody (Developmental Studies Hybridoma Bank) (Airey et al., 1990 ) diluted 1:200, followed by a 30 min incubation in rhodamine-conjugated goat anti-mouse secondary antibody (Sigma-Aldrich) diluted 1:2,000. Fluorescence visualized at 603 magnification using either YFP (for D-FKBP) or ReAsH (for RyR1 immunocytochemistry) cube sets was quantified from 60-image stacks acquired under identical conditions, using ImageJ. The ratio of D-FKBP fluorescence to RyR1 immunofluorescence was normalized to the corresponding ratio derived from cells expressing WT RyR1.
Ca
2+ Imaging
Transfected HEK293T cells were loaded for 30 min at 37 C with 5 mM Fluo-4/ AM in Ca 2+ imaging buffer containing 150 mM NaCl, 5 mM KCl, 1.2 mM MgSO 4 , 25 mM HEPES, 6 mM glucose, and 2 mM CaCl 2 . Cells were perfused with a graded series of caffeine concentrations in Ca 2+ imaging buffer, and changes in intracellular Ca 2+ were recorded as changes in Fluo-4 fluorescence intensity at 510 nm when the cells were excited at 480 nm. Normalized Ca 2+ transients were quantified as described (Fessenden, 2009) , and the data plotted as a function of caffeine concentration were fit to a sigmoidal doseresponse function (variable slope) to determine EC 50 values. Stepwise rotated view of RyR1 cryo-EM structure is shown with a putative location of the Ca v 1.1 cryo-EM structure (tan). The distance from our DR2 trilateration result (cyan) to GFP fused at position 1350 from a previously published study (green ball) (Liu et al., 2004 ) is indicated.
SUPPLEMENTAL INFORMATION
(C) The DR3 trilateration result (magenta) is shown relative to a GFP fusion at position 1908 (green ball) (Zhang et al., 2003) . We propose a location of the RyR1 polyacidic sequence spanning residues 1,873-1,920 as indicated (orange).
(D) DR1 trilateration result (yellow patch) relative to GFP fused at position 4413 (green ball) (Liu et al., 2002) 
